These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 446514)

  • 1. The binding of tamoxifen to oestrogen receptor proteins under equilibrium and non-equilibrium conditions.
    Nicholson RI; Syne JS; Daniel CP; Griffiths K
    Eur J Cancer (1965); 1979 Mar; 15(3):317-29. PubMed ID: 446514
    [No Abstract]   [Full Text] [Related]  

  • 2. Binding of [3H]tamoxifen in rat uterine cytosols: a comparison of swinging bucket and vertical tube rotor sucrose density gradient analysis.
    Jordan VC; Prestwich G
    Mol Cell Endocrinol; 1977 Sep; 8(3):179-88. PubMed ID: 924012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient and highly selective covalent labeling of the estrogen receptor with [3H]tamoxifen aziridine.
    Katzenellenbogen JA; Carlson KE; Heiman DF; Robertson DW; Wei LL; Katzenellenbogen BS
    J Biol Chem; 1983 Mar; 258(6):3487-95. PubMed ID: 6833211
    [No Abstract]   [Full Text] [Related]  

  • 4. Binding characteristics of zearalenone analogs to estrogen receptors.
    Kiang DT; Kennedy BJ; Pathre SV; Mirocha CJ
    Cancer Res; 1978 Nov; 38(11 Pt 1):3611-5. PubMed ID: 698923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of spironolactone with oestradiol receptors in cytosol.
    Levy J; Burshell A; Marbach M; Afllalo L; Glick SM
    J Endocrinol; 1980 Mar; 84(3):371-9. PubMed ID: 7391714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-affinity binding to the estrogen receptor of [3H]4-hydroxytamoxifen, an active antiestrogen metabolite.
    Borgna JL; Rochefort H
    Mol Cell Endocrinol; 1980 Oct; 20(1):71-85. PubMed ID: 7439523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation of estradiol receptors in rat uterine cytosol by sensitivity to tamoxifen.
    Fishman JH; Fishman J
    Biochem Biophys Res Commun; 1979 Mar; 87(2):550-8. PubMed ID: 444239
    [No Abstract]   [Full Text] [Related]  

  • 8. Quantitation of estrogen receptor in mammary carcinoma.
    McGuire WL
    Methods Enzymol; 1975; 36():248-54. PubMed ID: 162982
    [No Abstract]   [Full Text] [Related]  

  • 9. High-affinity binding of the antiestrogen [3H]tamoxifen to the 8S estradiol receptor.
    Capony F; Rochefort H
    Mol Cell Endocrinol; 1978; 11(2):181-98. PubMed ID: 680340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissimilarities between the uterine estrogen receptor in cytosol of castrated and estradiol-treated rats.
    Faye JC; Fargin A; Bayard F
    Endocrinology; 1986 Jun; 118(6):2276-83. PubMed ID: 3698914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-steroidal antioestrogens--receptor binding and biological response in rat uterus, rat mammary carcinoma and human breast cancer cells.
    Wakeling AE; Valcaccia B; Newboult E; Green LR
    J Steroid Biochem; 1984 Jan; 20(1):111-20. PubMed ID: 6538611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The presence of a second, specific estrogen binding site in human breast cancer.
    Panko WB; Watson CS; Clark JH
    J Steroid Biochem; 1981 Dec; 14(12):1311-6. PubMed ID: 7329065
    [No Abstract]   [Full Text] [Related]  

  • 13. The binding of tamoxifen to human mammary carcinoma cytosol.
    Sutherland RL; Murphy LC
    Eur J Cancer (1965); 1980 Sep; 16(9):1141-8. PubMed ID: 7227442
    [No Abstract]   [Full Text] [Related]  

  • 14. Heterogeneity of estrogen binding sites in mouse mammary cancer.
    Watson CS; Clark JH
    J Recept Res; 1980; 1(1):91-111. PubMed ID: 7299733
    [No Abstract]   [Full Text] [Related]  

  • 15. Chemotherapeutic agents and estradiol receptor binding capacity.
    Görlich M; Heise E; Számel I; Kerpel-Fronius S
    Oncology; 1979; 36(4):149-55. PubMed ID: 471426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physicochemical and genetic evidence for specific antiestrogen binding sites.
    Faye JC; Jozan S; Redeuilh G; Baulieu EE; Bayard F
    Proc Natl Acad Sci U S A; 1983 Jun; 80(11):3158-62. PubMed ID: 6574477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of antiestrogen-specific binding sites in normal and neoplastic mammary gland.
    Mehta RG; Cerny WL; Moon RC
    Oncology; 1984; 41(6):387-92. PubMed ID: 6504492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential binding of antiestrogens by rat uterine and chick oviduct cytosol.
    Sutherland RL; Foo MS
    Biochem Biophys Res Commun; 1979 Nov; 91(1):183-91. PubMed ID: 518621
    [No Abstract]   [Full Text] [Related]  

  • 19. A high-affinity binding site for the antioestrogens, tamoxifen and CI 628, in immature rat uterine cytosol which is distinct from the oestrogen receptor.
    Murphy LC; Sutherland RL
    J Endocrinol; 1981 Oct; 91(1):155-61. PubMed ID: 7028904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological activity of [127I] and [125I] estradiol analogs in vitro and in vivo.
    Longcope C; Arunachalam T; Rafkind I; Caspi E
    J Steroid Biochem; 1981 Mar; 14(3):261-8. PubMed ID: 6783784
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.